Z

Zura Bio Limited
D

ZURA

4.02000
USD
-0.02
(-0.50%)
مغلق
حجم التداول
16,812
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
261,393,698
المقالات

العنوان: Zura Bio Limited

القطاع: Healthcare
الصناعة: Biotechnology
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.